"Designing Growth Strategies is in our DNA"

U.S Secondary Hyperparathyroidism (SHPT) Treatment Market Size, Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others), and Region Forecast 2019-2026

The U.S secondary hyperparathyroidism (SHPT) treatment market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 7.06 billion by 2026, exhibiting a... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Nov, 2019 | Report ID: FBI101664 | Status : Published

 

Speak to Analyst

Refresh Button
U.S. Secondary Hyperparathyroidism (SHPT) Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 114
  • Direct Purchase
  • 2850
    4850
    6850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X